JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 16 October 2006. doi:10.1083/jcb.1752rr1
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 175, Number 2, 197-197
This Article
Right arrow Full Text (PDF, 969K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Roundup

Mopping up chemokines



Figure 1
Apoptotic cells (right) accumulate CCR5 (top right).

BOXER/MACMILLAN

In both Iraq and the immune system, it's not the initial victory but the subsequent cleaning up that is the hardest part. Now, Amiram Ariel, Charles Serhan (Harvard Medical School, Boston, MA), and colleagues show that the mess after an infection is cleared up in part by dying cells.

This very act of cell death—notably of neutrophils and T cells—is one way of actively resolving an inflammatory event. But the signals that first drew immune cells to the site of inflammation also need to be destroyed: chemicals via enzymatic degradation and proteins and peptides by other means. Now, the Boston team shows that some of these chemokine proteins are mopped up by apoptotic cells. These dying cells turn up expression of their CCR5 chemokine receptors even as the cells are about to be engulfed by macrophages.

CCR5 is important because it binds several key chemokines—"the lion's share of the chemokines at a site of inflammation," says Serhan. "So you need a good mechanism to explain their clearance."

Late apoptotic cells had higher CCR5 staining; this was reduced by a proinflammatory cytokine but increased by proresolution mediators. The result was more chemokine binding to late apoptotic cells. If CCR5 was knocked out or antagonized, however, fluid from resolving infections had higher chemokine levels.

Thus it appears that the dying cells are mopping up chemokines and taking them to the grave. "It sounds almost too simple," says Serhan, but he doesn't think this is his "Mission Accomplished." Rather it is a reminder, he says, that "when cells go through apoptosis they don't stop signaling." Formula

Reference:

Ariel, A., et al. 2006. Nat. Immunol. doi:10.1038/ni1392.



William A. Wells

wellsw{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 969K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents